CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group

Hyojin Kim, Hyo Sup Shim, Lucia Kim, Tae-Jung Kim, Kun Young Kwon, Geon Kook Lee, Jin-Haeng Chung,

JPTM. 2014;48(1):1-9. Published online 2014 February 25 DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.1.1

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology: Erratum

Journal of Thoracic Oncology. 2013;8(10):1343

Link1 Link2

Molecular Testing of Lung Cancers

Hyo Sup Shim, Yoon-La Choi, Lucia Kim, Sunhee Chang, Wan-Seop Kim, Mee Sook Roh, Tae-Jung Kim, Seung Yeon Ha, Jin-Haeng Chung, Se Jin Jang, Geon Kook Lee, ,

Journal of Pathology and Translational Medicine. 2017;51(3):242-254

Link1

Link2 Link3

Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing

Maximilian v. Laffert, Arne Warth, Roland Penzel, Peter Schirmacher, Danny Jonigk, Hans Kreipe, Hans-Ulrich Schildhaus, Sabine Merkelbach-Bruse, Reinhard Büttner, Simone Reu, Rosi Kerler, Andreas Jung, Thomas Kirchner, Cornelius Wölfel, Iver Petersen, Regulo Rodriguez, Wolfram Jochum, Holger Bartsch, Annette Fisseler-Eckhoff, Erika Berg, Dido Lenze, Manfred Dietel, Michael Hummel

Lung Cancer. 2013;81(2):200-206

Link1 Link2

Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?

Nobuaki Ochi, Hiromichi Yamane, Tomoko Yamagishi, Nagio Takigawa, Yasumasa Monobe

Lung Cancer. 2013;79(1):94-95

Link1 Link2

Concomitance of EGFR mutations and ALK rearrangement in patients with Lung Cancer

Hind Berradi, Houda Kaanane, Nadia El Kadmiri, Sellama Nadifi

Gene Reports. 2018;11:196-204

Link1 Link2

Comment on ‘Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization’

Etienne Mahe

Modern Pathology. 2014;27(10):1423-1424

Link1

Link2 Link3

ALK- rearrangement in non-small-cell lung cancer (NSCLC)

Xue Du, Yun Shao, Hai-Feng Qin, Yan-Hong Tai, Hong-Jun Gao

Thoracic Cancer. 2018;9(4):423-430

Link1 Link2

63: Crizotinib for ALK rearrangement in non small cell lung cancer

S.A. Merrick, S. Hunter, M. Dalby, M. Neat, E. McMunagle, A. Montes, R. Lal, S. Ghosh

Lung Cancer. 2017;103:S29-S30

Link1 Link2

2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology. 2015;16(3):465

Link1

Expanded Circulating Tumor Cells from a Patient with ALK- Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study

Zhuo Zhang, Hiroe Shiratsuchi, Nallasivam Palanisamy, Sunitha Nagrath, Nithya Ramnath

Journal of Thoracic Oncology. 2017;12(2):397-402

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.